Why is Bliss GVS Pharma falling/rising?

As of 28-Jul, Bliss GVS Pharma Ltd's stock price is currently at 155.10, reflecting an increase of 0.8, or 0.52%. The stock has been gaining for the last two days, with a total return of 1.27% during this period. However, over the past week, the stock has underperformed with a decline of 3.87%, while it has also seen a slight drop of 1.24% over the past month. Despite a strong performance over the last year with a return of 31.11%, the company's profits have fallen by 19.5%, indicating potential concerns about its profitability. The stock is trading at a premium compared to its peers, and while it has a low debt-to-equity ratio and a fair valuation, these factors may not be sufficient to offset the recent profit decline.
In the broader market context, the stock's recent performance contrasts with the benchmark Sensex, which has declined by 1.59% over the past week and 3.77% over the past month. This suggests that while Bliss GVS Pharma has faced challenges, it has managed to outperform the market in the short term. However, the falling investor participation, evidenced by a significant drop in delivery volume, may indicate waning interest among investors. Overall, while the stock has shown resilience in the long term, its recent price movements reflect a complex interplay of positive and negative factors that investors are weighing carefully.